Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

NCT07061145 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT07061145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07061145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2025
Completion date
December 31, 2028
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelocytic leukemia, cvd - cardiovascular disease, erectile dysfunctions, tyrosine kinase inhibitor